We develop therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs are: Disc/Spine Program brtxDISCTM : Our lead cell therapy candidate, BRTX , is a product formulated from autologous cultured mesenchymal stem cells collected from bone marrow. We intend that the product will be used for the non surgical treatment of protruding and bulging lumbar discs in patients suffering from chronic lumbar disc disease. The treatment is intended for patients whose pain has not been alleviated by non invasive procedures and who potentially face the prospect of surgery. We have received clearance from the Food and Drug Administration to commence a Phase clinical trial using BRTX to treat chronic lower back pain due to degenerative disc disease related to protruding/bulging discs. Metabolic Program ThermoStem : We are developing a cell based therapy to target obesity and metabolic disorders using brown adipose fat derived stem cells to generate brown adipose tissue BAT . BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in the body may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.
Quote | BioRestorative Therapies Inc (OTCMKTS:BRTX)
Last: | $7.02 |
---|---|
Change Percent: | 0.0% |
Open: | $7.85 |
Close: | $7.02 |
High: | $7.85 |
Low: | $6.6 |
Volume: | 208,081 |
Last Trade Date Time: | 11/08/2021 04:54:29 pm |
News | BioRestorative Therapies Inc (OTCMKTS:BRTX)
2024-04-16 09:53:30 ET More on BioRestorative Therapies, Inc. BioRestorative Therapies tumbles after private placement Seeking Alpha’s Quant Rating on BioRestorative Therapies, Inc. Historical earnings data for BioRestorative Therapies, Inc. Financial ...
2024-04-16 09:38:47 ET A New York-based %Biotech company is making major waves so far during Tuesday’s premarket hours after the company announced that the U.S. Food and Drug Administration (FDA) has cleared an important amendment to the protocol of the ongoing Phase 2 study inve...
Message Board Posts | BioRestorative Therapies Inc (OTCMKTS:BRTX)
Subject | By | Source | When |
---|---|---|---|
$BRTX | Hole shot King | investorshub | 07/06/2023 5:01:13 PM |
$BRTX bears are running | iflyboats | investorshub | 07/06/2023 8:35:29 AM |
$BRTX bears are running | 50 MIL STRONG | investorshub | 07/01/2023 6:15:19 PM |
$BRTX MomentumIts trading | trader59 | investorshub | 07/01/2023 1:09:02 PM |
Between the two, I'd vote Auctus, given the | I ll be back | investorshub | 06/30/2023 1:39:39 PM |
News, Short Squeeze, Breakout and More Instantly...
BioRestorative Therapies Inc Company Name:
BRTX Stock Symbol:
OTCMKTS Market:
BioRestorative Therapies Inc Website:
2024-04-16 09:38:47 ET A New York-based %Biotech company is making major waves so far during Tuesday’s premarket hours after the company announced that the U.S. Food and Drug Administration (FDA) has cleared an important amendment to the protocol of the ongoing Phase 2 study inve...
2024-04-16 09:29:31 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- Palisade Bio, Inc. (Nasdaq: PALI ), Brera Holding (NASDAQ: BREA ), Peraso Inc. (NASDAQ: PRSO ), BioRestorative Therapies, Inc. (NASDAQ: BRTX ), and Intra-Cellular Ther...
2024-04-16 08:04:07 ET DENVER, Colo., Apr 16, 2024 ( 247marketnews.com )- BioRestorative Therapies, Inc. (NASDAQ: BRTX ) stated that the U.S. Food and Drug Administration (“FDA”) cleared an important amendment to the protocol of the ongoing Phase 2 study investigating ...